State Department of Cardiology, Hippokration Hospital, 114 Vasilisis Sofias Street, 11528, Athens, Greece.
First Cardiology Division, University of Athens, Medical School, Hippokration Hospital, 114 Vasilisis Sofias Street, 11528, Athens, Greece.
Hellenic J Cardiol. 2017 Nov-Dec;58(6):403-410. doi: 10.1016/j.hjc.2017.05.004. Epub 2017 May 18.
Since the first transvenous pacemaker implantation, which took place 50 years ago, important progress has been achieved in pacing technology. Consequently, at present, more than 700,000 pacemakers are implanted annually worldwide. However, conventional pacemakers' implantation has a non-negligible risk of periprocedural and long-term complications associated with the transvenous leads and pacemaker pocket. Recently, leadless pacing systems have emerged as a therapeutic alternative to conventional pacing systems that provide therapy for patients with bradyarrhythmias, while eliminating potential transvenous lead- and pacemaker pocket-related complications. Initial studies have demonstrated favorable efficacy and safety of currently developed leadless pacing systems, compared to transvenous pacemakers. In the present paper, we review the current evidence and highlight the advantages and disadvantages of this novel technology. New technological advances may allow the next generation of leadless pacemakers to further expand, thereby offering a wireless cardiac pacing in future.
自 50 年前首例经静脉起搏器植入以来，起搏技术取得了重要进展。因此，目前全球每年植入的起搏器超过 70 万枚。然而，传统起搏器的植入术存在不可忽视的围术期和长期并发症风险，这些并发症与经静脉导线和起搏器囊袋有关。最近，无导线起搏系统作为传统起搏系统的治疗替代方法出现，为心动过缓患者提供治疗，同时消除潜在的经静脉导线和起搏器囊袋相关并发症。初步研究表明，与经静脉起搏器相比，目前开发的无导线起搏系统具有良好的疗效和安全性。本文综述了目前的证据，并强调了这项新技术的优缺点。新的技术进步可能使下一代无导线起搏器进一步扩大，从而在未来提供无线心脏起搏。
